These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 38413370)

  • 1. Cell cycle heterogeneity and plasticity of colorectal cancer stem cells.
    Higa T; Nakayama KI
    Cancer Sci; 2024 May; 115(5):1370-1377. PubMed ID: 38413370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
    Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
    Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.
    Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H
    Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells.
    Kemper K; Prasetyanti PR; De Lau W; Rodermond H; Clevers H; Medema JP
    Stem Cells; 2012 Nov; 30(11):2378-86. PubMed ID: 22969042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR56 Drives Colorectal Tumor Growth and Promotes Drug Resistance through Upregulation of MDR1 Expression via a RhoA-Mediated Mechanism.
    Zhang S; Chatterjee T; Godoy C; Wu L; Liu QJ; Carmon KS
    Mol Cancer Res; 2019 Nov; 17(11):2196-2207. PubMed ID: 31444231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
    Eun K; Ham SW; Kim H
    BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualization and targeting of LGR5
    Shimokawa M; Ohta Y; Nishikori S; Matano M; Takano A; Fujii M; Date S; Sugimoto S; Kanai T; Sato T
    Nature; 2017 May; 545(7653):187-192. PubMed ID: 28355176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution.
    Kobayashi S; Yamada-Okabe H; Suzuki M; Natori O; Kato A; Matsubara K; Jau Chen Y; Yamazaki M; Funahashi S; Yoshida K; Hashimoto E; Watanabe Y; Mutoh H; Ashihara M; Kato C; Watanabe T; Yoshikubo T; Tamaoki N; Ochiya T; Kuroda M; Levine AJ; Yamazaki T
    Stem Cells; 2012 Dec; 30(12):2631-44. PubMed ID: 23081779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma.
    Das PK; Islam F; Lam AK
    Cells; 2020 Jun; 9(6):. PubMed ID: 32503256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clusterin: a marker and mediator of chemoresistance in colorectal cancer.
    Hlavca S; Chan WH; Engel RM; Abud HE
    Cancer Metastasis Rev; 2024 Mar; 43(1):379-391. PubMed ID: 38319453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
    Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ
    Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Implications of Colorectal Cancer Stem Cells in the Age of Single-Cell Omics and Targeted Therapies.
    Frank MH; Wilson BJ; Gold JS; Frank NY
    Gastroenterology; 2021 May; 160(6):1947-1960. PubMed ID: 33617889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
    Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
    Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the Role of Intestinal Crypt Cell Populations in Resistance to Chemotherapy.
    Frau C; Jamard C; Delpouve G; Guardia GDA; Machon C; Pilati C; Nevé CL; Laurent-Puig P; Guitton J; Galante PAF; Penalva LO; Freund JN; de la Fouchardiere C; Plateroti M
    Cancer Res; 2021 May; 81(10):2730-2744. PubMed ID: 33741693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.
    De Angelis ML; Zeuner A; Policicchio E; Russo G; Bruselles A; Signore M; Vitale S; De Luca G; Pilozzi E; Boe A; Stassi G; Ricci-Vitiani L; Amoreo CA; Pagliuca A; Francescangeli F; Tartaglia M; De Maria R; Baiocchi M
    Stem Cells Transl Med; 2016 Apr; 5(4):511-23. PubMed ID: 26956206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spheroid-Formation (Colonosphere) Assay for in Vitro Assessment and Expansion of Stem Cells in Colon Cancer.
    Shaheen S; Ahmed M; Lorenzi F; Nateri AS
    Stem Cell Rev Rep; 2016 Aug; 12(4):492-9. PubMed ID: 27207017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cancer stem cells from different grades of human colorectal cancer.
    Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
    Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intestinal stem cell as a target: A review.
    Faizo NL
    Medicine (Baltimore); 2024 Aug; 103(34):e39456. PubMed ID: 39183418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer?
    Mirzaei A; Tavoosidana G; Rad AA; Rezaei F; Tavakoli-Yaraki M; Kadijani AA; Khalili E; Madjd Z
    Tumour Biol; 2016 Feb; 37(2):2405-14. PubMed ID: 26383518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.